Position in EXEL
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,114,948
+$137,164 QoQ
Shares Held
49,311
+9.3% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PINEBRIDGE INVESTMENTS LLC holds $213,040,195 across 7 Biotechnology names. EXEL ranks #6 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
271,419 | $89,804,404 | |
| 2 | ARGX |
Argenx SE
|
103,812 | $75,808,713 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
55,100 | $24,604,354 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
13,307 | $10,281,520 | |
| 5 | INCY |
Incyte Corp
|
102,979 | $9,692,383 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
49,311 | $2,114,948 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
11,355 | $733,873 |
All Filings in EXEL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,114,948 | 49,311 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,977,784 | 45,124 | Shares | Sole | 2026-02-12 | |
| No filing history on record for this holder in this stock. | ||||||